Rituximab and COVID-19 infection in patients with autoimmune rheumatic diseases – A real-world study from India

Rituximab and COVID-19 infection in patients with autoimmune rheumatic diseases – A real-world study from India

Introduction: Safety of rituximab (RTX) in autoimmune rheumatic diseases (AIRDs) has been a concern during this ongoing coronavirus (COVID-19) pandemic. Delayed worsening of COVID symptoms, increased hospital stays, and mortality has been reported among those infected post-RTX. This study describes...

Full description

Bibliographic Details
Main Authors: Aswin M Nair, A S Chandhu, Mohammed Tanveer Zafar, G Vinodini, Bijesh Yadav, Shivraj Padiyar, Arvind Ganapati, John Mathew
Format: Article
Language:English
Published: SAGE Publications 2023-01-01
Series:Indian Journal of Rheumatology
Subjects:
autoimmune rheumatic diseases
covid-19 infection
outcome
rituximab
vaccination
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2023;volume=18;issue=2;spage=154;epage=158;aulast=Nair

Internet

http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2023;volume=18;issue=2;spage=154;epage=158;aulast=Nair

Similar Items